Recent developments in processing systems for cell and tissue cultures toward therapeutic application.

Innovative techniques of cell and tissue processing, based on tissue engineering, have been developed for therapeutic applications. Cell expansion and tissue reconstruction through ex vivo cultures are core processes used to produce engineered tissues with sufficient structural integrity and functionality. In manufacturing, strict management against contamination and human error is compelled due to direct use of un-sterilable products and the laboriousness of culture operations, respectively. Therefore, the development of processing systems for cell and tissue cultures is one of the critical issues for ensuring a stable process and quality of therapeutic products. However, the siting criterion of culture systems to date has not been made clear. This review article classifies some of the known processing systems into 'sealed-chamber' and 'sealed-vessel' culture systems based on the difference in their aseptic spaces, and describes the potential advantages of these systems and current states of culture systems, especially those established by Japanese companies. Moreover, on the basis of the guidelines for isolator systems used in aseptic processing for healthcare products, which are issued by the International Organization for Standardization, the siting criterion of the processing systems for cells and tissue cultures is discussed in perspective of manufacturing therapeutic products in consideration of the regulations according to the Good Manufacturing Practice.

[1]  P. Rolfe Sensing in tissue bioreactors , 2006 .

[2]  R M Nerem,et al.  Tissue engineering: from biology to biological substitutes. , 1995, Tissue engineering.

[3]  H. Ohgushi,et al.  Development of Cell Culture System Equipped with Automated Observation Function , 2007 .

[4]  N. Kotov,et al.  Three-dimensional cell culture matrices: state of the art. , 2008, Tissue engineering. Part B, Reviews.

[5]  S. Mizuno,et al.  Hydrostatic pressure/perfusion culture system designed and validated for engineering tissue. , 2005, Journal of bioscience and bioengineering.

[6]  Oliver Brüstle,et al.  Automated maintenance of embryonic stem cell cultures , 2007, Biotechnology and bioengineering.

[7]  Richard Archer,et al.  Why tissue engineering needs process engineering , 2005, Nature Biotechnology.

[8]  H. Prince,et al.  Regulation of cellular therapies: the Australian perspective. , 2003, Cytotherapy.

[9]  D. Wendt,et al.  The role of bioreactors in tissue engineering. , 2004, Trends in biotechnology.

[10]  J E Prenosil,et al.  Development of an on-line monitoring system of human keratinocyte growth by image analysis and its application to bioreactor culture. , 2000, Biotechnology and bioengineering.

[11]  Ashok Kumar,et al.  Skin tissue engineering for tissue repair and regeneration. , 2008, Tissue engineering. Part B, Reviews.

[12]  Kyung A Kang Tissue Engineering as a Subdivision of Bioprocess Engineering , 2002, Annals of the New York Academy of Sciences.

[13]  A. Farrugia When do tissues and cells become products? – Regulatory oversight of emerging biological therapies , 2006, Cell and Tissue Banking.

[14]  D J Williams,et al.  Application of process quality engineering techniques to improve the understanding of the in vitro processing of stem cells for therapeutic use. , 2008, Journal of biotechnology.

[15]  David J. Williams,et al.  Manufacture of a human mesenchymal stem cell population using an automated cell culture platform , 2007, Cytotechnology.

[16]  M. Rao Scalable human ES culture for therapeutic use: propagation, differentiation, genetic modification and regulatory issues , 2008, Gene Therapy.

[17]  L. Griffith,et al.  Tissue Engineering--Current Challenges and Expanding Opportunities , 2002, Science.

[18]  S. Forman,et al.  Manufacturing of Large Numbers of Patient-specific T Cells for Adoptive Immunotherapy: An Approach to Improving Product Safety, Composition, and Production Capacity , 2007, Journal of immunotherapy.

[19]  Masahiro Kino-Oka,et al.  Automating the expansion process of human skeletal muscle myoblasts with suppression of myotube formation. , 2009, Tissue engineering. Part C, Methods.

[20]  M. Hoare,et al.  The impact of process stress on suspended anchorage‐dependent mammalian cells as an indicator of likely challenges for regenerative medicines , 2008, Biotechnology and bioengineering.

[21]  Masahiro Kino-Oka,et al.  Bioreactor design for successive culture of anchorage-dependent cells operated in an automated manner. , 2005, Tissue engineering.

[22]  F. Hesse,et al.  Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures. , 2000, Trends in biotechnology.

[23]  S. Mizuno,et al.  Hydrostatic fluid pressure promotes cellularity and proliferation of human dermal fibroblasts in a three-dimensional collagen gel/sponge , 2004 .

[24]  G. Tripodi,et al.  A sealed and unbreached system for purification, stimulation, and expansion of cytomegalovirus‐specific human CD4 and CD8 T lymphocytes , 2006, Transfusion.

[25]  S. Boyce,et al.  Fabrication, quality assurance, and assessment of cultured skin substitutes for treatment of skin wounds , 2004 .

[26]  G. Williams,et al.  Validation of a quality assurance program for autologous cultured chondrocyte implantation. , 1998, Tissue engineering.

[27]  M. Kino‐oka,et al.  Design and Operation of a Radial Flow Bioreactor for Reconstruction of Cultured Tissues , 2005 .

[28]  H. Kurosawa Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. , 2007, Journal of bioscience and bioengineering.

[29]  Gary C du Moulin,et al.  Development of a regulatory strategy for the cellular therapies : an American perspective , 2000 .

[30]  R. Langer,et al.  Tissue engineering: current state and perspectives , 2004, Applied Microbiology and Biotechnology.

[31]  K. Lin,et al.  Characterization of adipose tissue-derived cells isolated with the Celution system. , 2008, Cytotherapy.

[32]  E. Burchardt,et al.  Tissue repair cells for the treatment of cardiovascular diseases , 2007 .

[33]  Masahiro Kino-Oka,et al.  A kinetic modeling of chondrocyte culture for manufacture of tissue-engineered cartilage. , 2005, Journal of bioscience and bioengineering.

[34]  Anthony Ratcliffe,et al.  Bioreactors and Bioprocessing for Tissue Engineering , 2002, Annals of the New York Academy of Sciences.

[35]  M. Kino‐oka,et al.  Cell behavior analysis to evaluate proliferative potentials of human lymphocytes expanded and activated for therapeutic use. , 2008, Journal of bioscience and bioengineering.

[36]  J. Polak,et al.  Stem Cells Bioprocessing: An Important Milestone to Move Regenerative Medicine Research Into the Clinical Arena , 2008, Pediatric Research.

[37]  Jiake Xu,et al.  The chondrocyte: biology and clinical application. , 2006, Tissue engineering.

[38]  Toshiomi Yoshida,et al.  Cell processing engineering for ex vivo expansion of hematopoietic cells: a review , 2004 .

[39]  Ivan Martin,et al.  Bioreactor-based engineering of osteochondral grafts: from model systems to tissue manufacturing. , 2005, Journal of bioscience and bioengineering.

[40]  Athanasios Mantalaris,et al.  Intelligent bioprocessing for haemotopoietic cell cultures using monitoring and design of experiments. , 2007, Biotechnology advances.

[41]  M. Casati,et al.  Physiological features of periodontal regeneration and approaches for periodontal tissue engineering utilizing periodontal ligament cells. , 2007, Journal of bioscience and bioengineering.

[42]  Irene Georgakoudi,et al.  Optical spectroscopy and imaging for the noninvasive evaluation of engineered tissues. , 2008, Tissue engineering. Part B, Reviews.

[43]  D J Williams,et al.  Tissue engineering and regenerative medicine: manufacturing challenges. , 2005, IEE proceedings. Nanobiotechnology.

[44]  D. Alotto,et al.  The role of quality control in a skin bank: tissue viability determination. , 2004, Cell and Tissue Banking.

[45]  Alan Colman,et al.  Cell therapy and the safety of embryonic stem cell-derived grafts. , 2007, Trends in biotechnology.

[46]  H. Honda,et al.  Effective cell-seeding technique using magnetite nanoparticles and magnetic force onto decellularized blood vessels for vascular tissue engineering. , 2007, Journal of bioscience and bioengineering.

[47]  Chris Mason,et al.  The impact of manual processing on the expansion and directed differentiation of embryonic stem cells , 2008, Biotechnology and bioengineering.

[48]  David J. Williams,et al.  Cell Culture Automation and Quality Engineering: A Necessary Partnership to Develop Optimized Manufacturing Processes for Cell-Based Therapies , 2008 .

[49]  M. Dilber,et al.  The derivation of clinical‐grade human embryonic stem cell lines , 2006, FEBS letters.

[50]  Shadi F Othman,et al.  Monitoring tissue engineering using magnetic resonance imaging. , 2008, Journal of bioscience and bioengineering.

[51]  Adam M. Larson,et al.  Advances in nonlinear optical microscopy for visualizing dynamic tissue properties in culture. , 2008, Tissue engineering. Part B, Reviews.

[52]  Chris Mason,et al.  Regenerative medicine bioprocessing: building a conceptual framework based on early studies. , 2006, Tissue engineering.

[53]  M. Kino‐oka,et al.  Monitoring of monolayer and multilayer growth for epithelial sheet formation , 2006 .

[54]  Masahiro Kino-Oka,et al.  Quality control of cultured tissues requires tools for quantitative analyses of heterogeneous features developed in manufacturing process , 2009, Cell and Tissue Banking.

[55]  Ralf Pörtner,et al.  Bioreactor design for tissue engineering. , 2005, Journal of bioscience and bioengineering.

[56]  David J. Williams,et al.  Cell therapies: realizing the potential of this new dimension to medical therapeutics , 2008, Journal of tissue engineering and regenerative medicine.